$1.49
0.00% yesterday
Nasdaq, May 20, 10:00 pm CET
ISIN
US03837C1062
Symbol
APYX

Apyx Medical Corporation Stock price

$1.49
+0.51 52.04% 1M
+0.09 6.43% 6M
-0.09 5.70% YTD
-0.11 6.88% 1Y
-2.03 57.67% 3Y
-3.40 69.53% 5Y
-5.20 77.73% 10Y
Nasdaq, Closing price Tue, May 20 2025
+0.00 0.00%
ISIN
US03837C1062
Symbol
APYX
Sector

Key metrics

Market capitalization $56.31m
Enterprise Value $64.35m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.36
P/S ratio (TTM) P/S ratio 1.19
P/B ratio (TTM) P/B ratio 5.36
Revenue growth (TTM) Revenue growth -6.27%
Revenue (TTM) Revenue $47.29m
EBIT (operating result TTM) EBIT $-15.28m
Free Cash Flow (TTM) Free Cash Flow $-13.16m
Cash position $31.01m
EPS (TTM) EPS $-0.55
P/E forward negative
P/S forward 1.17
EV/Sales forward 1.33
Short interest 0.73%
Show more

Is Apyx Medical Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Apyx Medical Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

3 Analysts have issued a Apyx Medical Corporation forecast:

1x Buy
33%
2x Hold
67%

Analyst Opinions

3 Analysts have issued a Apyx Medical Corporation forecast:

Buy
33%
Hold
67%

Financial data from Apyx Medical Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
47 47
6% 6%
100%
- Direct Costs 34 34
10% 10%
72%
13 13
4% 4%
28%
- Selling and Administrative Expenses 24 24
16% 16%
50%
- Research and Development Expense 4.49 4.49
12% 12%
9%
-15 -15
28% 28%
-31%
- Depreciation and Amortization 0.58 0.58
11% 11%
1%
EBIT (Operating Income) EBIT -15 -15
27% 27%
-32%
Net Profit -20 -20
12% 12%
-42%

In millions USD.

Don't miss a Thing! We will send you all news about Apyx Medical Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Apyx Medical Corporation Stock News

Neutral
GlobeNewsWire
8 days ago
The AYON Body Contouring System is the first FDA cleared all-in-one platform for the aesthetic surgical suite Plan to initiate the commercial launch of the AYON Body Contouring System to key opinion leader surgeons in critical geographies during the second half of 2025 CLEARWATER, Fla., May 13, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical”; the “Company”), the ...
Neutral
Seeking Alpha
10 days ago
Apyx Medical Corporation (NASDAQ:APYX ) Q1 2025 Earnings Conference Call May 8, 2025 8:00 AM ET Company Participants Jeremy Feffer – LifeSci Advisors Charlie Goodwin – Chief Executive Officer Matt Hill – Chief Financial Officer Conference Call Participants Matt Hewitt – Craig-Hallum Capital Group Sam Eiber – BTIG Operator Ladies and gentlemen, good morning, and welcome to the Apyx Medical First...
Neutral
PRNewsWire
20 days ago
Beloved Personality of "The Real Housewives of New Jersey" Provides a Real Take on the Problem of Loose Skin and the Power of Body Contouring Technology CLEARWATER, Fla. , May 1, 2025 /PRNewswire/ -- Apyx® Medical Corporation (NASDAQ:APYX) ("Apyx Medical;" the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency platform technology marketed and sold as Renuvion® today ...
More Apyx Medical Corporation News

Company Profile

Apyx Medical Corp. operates as an energy-based medical technology company. The firm engages in developing, manufacturing, and marketing a range of electrosurgical products and technologies, as well as related medical products used the offices of doctors, surgery centers, and hospitals worldwide. It operates through the following segments: Advanced Energy and Original Equipment Manufacture (OME). The company was founded by Andrew Makrides in 1978 and is headquartered in Clearwater, FL.

Head office United States
CEO Charles Goodwin
Employees 220
Founded 1978
Website apyxmedical.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today